Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 23

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 23
---
16(a) of the Securities Exchange Act of 1934, as amended (“Exchange
Act”), requires our directors and executive officers, and beneficial owners of more than ten percent of our common stock to file
with the SEC initial reports of ownership of our equity securities on Form 3 and reports of changes in ownership of our equity securities
on Form 4 or Form 5. Such persons are required by SEC regulations to furnish us with copies of all such reports they file.

To our knowledge, based solely on a review of reports filed with the SEC,
we believe that all required reports applicable to our directors, executive officers, and beneficial owners of more than ten percent of
our common stock were timely filed under Section 16(a) for fiscal year 2025, except for the reports filed by Cuong Do (Forms 4 filed on
July 12, 2024, January 7, 2025 and August 13, 2025), Joanne Wendy Kim (Forms 4 filed on July 12, 2024 and January 7, 2025), Joseph M.
Palumbo (Forms 4 filed on July 12, 2024 and January 7, 2025), Richard Berman (Form 4 filed on January 7, 2025), Robert J. Hariri (Form
4 filed on January 7, 2025), James Lang (Form 4 filed on January 7, 2025), Sigmund Rogich (Form 4 filed on January 7, 2025) and Michael
Sherman (Form 4 filed on January 7, 2025).

Anti-Hedging Policy

We have adopted an insider trading policy that includes a provision restricting
trading of any interest or provision relating to the future price of our securities, such as a put, call or short sale.

| -14- |

<div align='center'>EXECUTIVE COMPENSATION</div>

Summary Compensation Table

The following table sets forth the total compensation paid during the last
two fiscal years ended June 30, 2025 and 2024 to the following executive officers of the Company, who are referred to as our named executive
officers (“NEOs”):

| ● | Cuong Do, our President and Chief 
 Executive Officer                 |

| ● | Joanne Wendy Kim, our Chief Financial 
 Officer and Corporate Secretary       |

| ● | Joseph Palumbo, our Chief Medical 
 Officer                           |

| Name and                                        
 Principal